(Q46830735)

25 December 2017

title

Targeting the EP1 receptor reduces Fas ligand expression and increases the antitumor immune response in an in vivo model of colon cancer (English)

1 reference

25 December 2017

author

Fergus Shanahan

5

1 reference

25 December 2017

author name string

Grace O'Callaghan

1

1 reference

25 December 2017

Aideen Ryan

2

1 reference

25 December 2017

Peter Neary

3

1 reference

25 December 2017

Caitlin O'Mahony

4

1 reference

25 December 2017

Aileen Houston

6

1 reference

25 December 2017

language of work or name

English

0 references

publication date

4 March 2013

1 reference

25 December 2017

International Journal of Cancer

published in

1 reference

25 December 2017

volume

133

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

825-834

1 reference

25 December 2017

Prostaglandins and cancer

cites work

1 reference

Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer

21 January 2018

1 reference

21 January 2018

Eicosanoids and cancer

1 reference

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

21 January 2018

1 reference

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

21 January 2018

1 reference

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

21 January 2018

1 reference

NSAIDs and cancer prevention: targets downstream of COX-2.

21 January 2018

1 reference

Targeting prostaglandin E EP receptors to inhibit metastasis

21 January 2018

1 reference

Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells.

21 January 2018

1 reference

Prostaglandin E receptor subtype EP(1) deficiency inhibits colon cancer development.

21 January 2018

1 reference

Suppression of azoxymethane-induced colon cancer development in rats by a prostaglandin E receptor EP1-selective antagonist.

21 January 2018

1 reference

Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice

21 January 2018

1 reference

Inhibition of prostaglandin E(2) signaling through the EP(1) receptor does not affect prostacyclin production in human endothelial cells

21 January 2018

1 reference

COX-2 inhibitors and cardiovascular risk

21 January 2018

1 reference

Addressing the "Fas counterattack" controversy: blocking fas ligand expression suppresses tumor immune evasion of colon cancer in vivo.

21 January 2018

1 reference

CD95 promotes tumour growth

21 January 2018

1 reference

Regulation of immune responses by prostaglandin E2

21 January 2018

1 reference

M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells

21 January 2018

1 reference

Resazurin assay of radiation response in cultured cells

21 January 2018

1 reference

Inhibitory effect of a prostaglandin E receptor subtype EP(1) selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice

21 January 2018

1 reference

Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: role of proteases

21 January 2018

1 reference

Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy

21 January 2018

1 reference

The Fas signalling pathway and its role in the pathogenesis of cancer

21 January 2018

1 reference

Life and death by death receptors

21 January 2018

1 reference

Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex

21 January 2018

1 reference

Receptors for prostaglandin E(2) that regulate cellular immune responses in the mouse

21 January 2018

1 reference

Il-9 stimulates release of chemotactic factors from human bronchial epithelial cells

21 January 2018

1 reference

In vitro and in vivo activated T cells display increased sensitivity to PGE2.

21 January 2018

1 reference

CD8(+) T cells specific for tumor antigens can be rendered dysfunctional by the tumor microenvironment through upregulation of the inhibitory receptors BTLA and PD-1.

21 January 2018

1 reference

21 January 2018

1 reference

Tumor cyclooxygenase-2/prostaglandin E2-dependent promotion of FOXP3 expression and CD4+ CD25+ T regulatory cell activities in lung cancer

21 January 2018

1 reference

Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner

21 January 2018

1 reference

Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy

21 January 2018

1 reference

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

21 January 2018

1 reference

CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages.

21 January 2018

1 reference

Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development

21 January 2018

1 reference

Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.28076

1 reference

25 December 2017

release_gda4wio7bjakfpc2ipxeeofy6q

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/gda4wio7bjakfpc2ipxeeofy6q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

25 December 2017